Explore
Validate
Learn
Flow cytometryAntibody data
- Antibody Data
- Antigen structure
- References [33]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- APS0308 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Anti-CD3e Monoclonal Antibody (FN-18), FITC
- Antibody type
- Monoclonal
- Antigen
- Other
- Host
- Mouse
- Conjugate
- Green dye
- Isotype
- IgG
- Antibody clone number
- FN-18
- Vial size
- 100 Tests
- Concentration
- Lot Dependent
- Storage
- 4° C
Submitted references Biocompatible anionic polymeric microspheres as priming delivery system for effetive HIV/AIDS Tat-based vaccines.
Small intestine CD4+ cell reduction and enteropathy in simian/human immunodeficiency virus KS661-infected rhesus macaques in the presence of low viral load.
Better protective effects in rhesus macaques by combining systemic and mucosal application of a dual component vector vaccine after rectal SHIV89.6P challenge compared to systemic vaccination alone.
Contribution of monocytes to viral replication in macaques during acute infection with simian immunodeficiency virus.
Pathology and virus dispersion in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus via different inoculation routes.
GM-CSF DNA: an adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccine.
Multiprotein genetic vaccine in the SIV-Macaca animal model: a promising approach to generate sterilizing immunity to HIV infection.
Rapid dissemination of a pathogenic simian/human immunodeficiency virus to systemic organs and active replication in lymphoid tissues following intrarectal infection.
Impaired T-cell differentiation in the thymus at the early stages of acute pathogenic chimeric simian-human immunodeficiency virus (SHIV) infection in contrast to less pathogenic SHIV infection.
Protective efficacy of nonpathogenic nef-deleted SHIV vaccination combined with recombinant IFN-gamma administration against a pathogenic SHIV challenge in rhesus monkeys.
Protective efficacy of nonpathogenic nef-deleted SHIV vaccination combined with recombinant IFN-gamma administration against a pathogenic SHIV challenge in rhesus monkeys.
Early virological events in various tissues of newborn monkeys after intrarectal infection with pathogenic simian human immunodeficiency virus.
Cellulose acetate 1,2-benzenedicarboxylate protects against challenge with pathogenic X4 and R5 simian/human immunodeficiency virus.
Cellulose acetate 1,2-benzenedicarboxylate protects against challenge with pathogenic X4 and R5 simian/human immunodeficiency virus.
Signature for long-term vaccine-mediated control of a Simian and human immunodeficiency virus 89.6P challenge: stable low-breadth and low-frequency T-cell response capable of coproducing gamma interferon and interleukin-2.
The immune response of the Chacma baboon to Bacille Calmette Guerin: development of a primate model for BCG-based vaccine research.
A CCR5-tropic simian-HIV molecular clone capable of inducing AIDS in rhesus macaques.
A CCR5-tropic simian-HIV molecular clone capable of inducing AIDS in rhesus macaques.
Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination.
Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination.
Simian immunodeficiency virus infection of CD4+CD8+ T cells in a macaque with an unusually high peripheral CD4+CD8+ T lymphocyte count.
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
Infection of macaques with a molecular clone, SHIVSF33A2, provides evidence for tissue specific variants.
CD3 polymorphism in cynomolgus monkeys (Macaca fascicularis).
The novel immunosuppressant FTY720 induces peripheral lymphodepletion of both T- and B-cells in cynomolgus monkeys when given alone, with Cyclosporine Neoral or with RAD.
One-round determination of seven leukocyte subsets in rhesus macaque blood by flow cytometry.
One-round determination of seven leukocyte subsets in rhesus macaque blood by flow cytometry.
Importance of the CD3 marker for evaluating changes in rhesus macaque CD4/CD8 T-cell ratios.
Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus.
Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus.
Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection.
Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection.
Control mechanisms of virus replication in naturally SIVsmm infected mangabeys and experimentally infected macaques.
Titti F, Maggiorella MT, Ferrantelli F, Sernicola L, Bellino S, Collacchi B, Fanales Belasio E, Moretti S, Pavone Cossut MR, Belli R, Olivieri E, Farcomeni S, Compagnoni D, Michelini Z, Sabbatucci M, Sparnacci K, Tondelli L, Laus M, Cafaro A, Caputo A, Ensoli B
PloS one 2014;9(10):e111360
PloS one 2014;9(10):e111360
Small intestine CD4+ cell reduction and enteropathy in simian/human immunodeficiency virus KS661-infected rhesus macaques in the presence of low viral load.
Inaba K, Fukazawa Y, Matsuda K, Himeno A, Matsuyama M, Ibuki K, Miura Y, Koyanagi Y, Nakajima A, Blumberg RS, Takahashi H, Hayami M, Igarashi T, Miura T
The Journal of general virology 2010 Mar;91(Pt 3):773-81
The Journal of general virology 2010 Mar;91(Pt 3):773-81
Better protective effects in rhesus macaques by combining systemic and mucosal application of a dual component vector vaccine after rectal SHIV89.6P challenge compared to systemic vaccination alone.
Stolte-Leeb N, Bieler K, Kostler J, Heeney J, Haaft PT, Suh YS, Hunsmann G, Stahl-Hennig C, Wagner R
Viral immunology 2008 Jun;21(2):235-46
Viral immunology 2008 Jun;21(2):235-46
Contribution of monocytes to viral replication in macaques during acute infection with simian immunodeficiency virus.
Kuwata T, Kodama M, Sato A, Suzuki H, Miyazaki Y, Miura T, Hayami M
AIDS research and human retroviruses 2007 Mar;23(3):372-80
AIDS research and human retroviruses 2007 Mar;23(3):372-80
Pathology and virus dispersion in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus via different inoculation routes.
Nagata N, Iwata N, Hasegawa H, Sato Y, Morikawa S, Saijo M, Itamura S, Saito T, Ami Y, Odagiri T, Tashiro M, Sata T
International journal of experimental pathology 2007 Dec;88(6):403-14
International journal of experimental pathology 2007 Dec;88(6):403-14
GM-CSF DNA: an adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccine.
Lai L, Vödrös D, Kozlowski PA, Montefiori DC, Wilson RL, Akerstrom VL, Chennareddi L, Yu T, Kannanganat S, Ofielu L, Villinger F, Wyatt LS, Moss B, Amara RR, Robinson HL
Virology 2007 Dec 5;369(1):153-67
Virology 2007 Dec 5;369(1):153-67
Multiprotein genetic vaccine in the SIV-Macaca animal model: a promising approach to generate sterilizing immunity to HIV infection.
Maggiorella MT, Sernicola L, Crostarosa F, Belli R, Pavone-Cossut MR, Macchia I, Farcomeni S, Tenner-Racz K, Racz P, Ensoli B, Titti F
Journal of medical primatology 2007 Aug;36(4-5):180-94
Journal of medical primatology 2007 Aug;36(4-5):180-94
Rapid dissemination of a pathogenic simian/human immunodeficiency virus to systemic organs and active replication in lymphoid tissues following intrarectal infection.
Miyake A, Ibuki K, Enose Y, Suzuki H, Horiuchi R, Motohara M, Saito N, Nakasone T, Honda M, Watanabe T, Miura T, Hayami M
The Journal of general virology 2006 May;87(Pt 5):1311-20
The Journal of general virology 2006 May;87(Pt 5):1311-20
Impaired T-cell differentiation in the thymus at the early stages of acute pathogenic chimeric simian-human immunodeficiency virus (SHIV) infection in contrast to less pathogenic SHIV infection.
Motohara M, Ibuki K, Miyake A, Fukazawa Y, Inaba K, Suzuki H, Masuda K, Minato N, Kawamoto H, Nakasone T, Honda M, Hayami M, Miura T
Microbes and infection 2006 May;8(6):1539-49
Microbes and infection 2006 May;8(6):1539-49
Protective efficacy of nonpathogenic nef-deleted SHIV vaccination combined with recombinant IFN-gamma administration against a pathogenic SHIV challenge in rhesus monkeys.
Kaneyasu K, Kita M, Ohkura S, Yamamoto T, Ibuki K, Enose Y, Sato A, Kodama M, Miura T, Hayami M
Microbiology and immunology 2005;49(12):1083-94
Microbiology and immunology 2005;49(12):1083-94
Protective efficacy of nonpathogenic nef-deleted SHIV vaccination combined with recombinant IFN-gamma administration against a pathogenic SHIV challenge in rhesus monkeys.
Kaneyasu K, Kita M, Ohkura S, Yamamoto T, Ibuki K, Enose Y, Sato A, Kodama M, Miura T, Hayami M
Microbiology and immunology 2005;49(12):1083-94
Microbiology and immunology 2005;49(12):1083-94
Early virological events in various tissues of newborn monkeys after intrarectal infection with pathogenic simian human immunodeficiency virus.
Miyake A, Ibuki K, Suzuki H, Horiuchi R, Saito N, Motohara M, Hayami M, Miura T
Journal of medical primatology 2005 Oct;34(5-6):294-302
Journal of medical primatology 2005 Oct;34(5-6):294-302
Cellulose acetate 1,2-benzenedicarboxylate protects against challenge with pathogenic X4 and R5 simian/human immunodeficiency virus.
Boadi T, Schneider E, Chung S, Tsai L, Gettie A, Ratterree M, Blanchard J, Neurath AR, Cheng-Mayer C
AIDS (London, England) 2005 Oct 14;19(15):1587-94
AIDS (London, England) 2005 Oct 14;19(15):1587-94
Cellulose acetate 1,2-benzenedicarboxylate protects against challenge with pathogenic X4 and R5 simian/human immunodeficiency virus.
Boadi T, Schneider E, Chung S, Tsai L, Gettie A, Ratterree M, Blanchard J, Neurath AR, Cheng-Mayer C
AIDS (London, England) 2005 Oct 14;19(15):1587-94
AIDS (London, England) 2005 Oct 14;19(15):1587-94
Signature for long-term vaccine-mediated control of a Simian and human immunodeficiency virus 89.6P challenge: stable low-breadth and low-frequency T-cell response capable of coproducing gamma interferon and interleukin-2.
Sadagopal S, Amara RR, Montefiori DC, Wyatt LS, Staprans SI, Kozyr NL, McClure HM, Moss B, Robinson HL
Journal of virology 2005 Mar;79(6):3243-53
Journal of virology 2005 Mar;79(6):3243-53
The immune response of the Chacma baboon to Bacille Calmette Guerin: development of a primate model for BCG-based vaccine research.
Chege GK, Williamson AL, Passmore JS, Bourn W, Ryffel B, Shephard EG
Vaccine 2005 Dec 30;23(50):5783-91
Vaccine 2005 Dec 30;23(50):5783-91
A CCR5-tropic simian-HIV molecular clone capable of inducing AIDS in rhesus macaques.
Hsu M, Ho SH, Balfe P, Gettie A, Harouse J, Blanchard J, Cheng-Mayer C
Journal of acquired immune deficiency syndromes (1999) 2005 Dec 1;40(4):383-7
Journal of acquired immune deficiency syndromes (1999) 2005 Dec 1;40(4):383-7
A CCR5-tropic simian-HIV molecular clone capable of inducing AIDS in rhesus macaques.
Hsu M, Ho SH, Balfe P, Gettie A, Harouse J, Blanchard J, Cheng-Mayer C
Journal of acquired immune deficiency syndromes (1999) 2005 Dec 1;40(4):383-7
Journal of acquired immune deficiency syndromes (1999) 2005 Dec 1;40(4):383-7
Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination.
Enose Y, Kita M, Yamamoto T, Suzuki H, Miyake A, Horiuchi R, Ibuki K, Kaneyasu K, Kuwata T, Takahashi E, Sakai K, Shinohara K, Miura T, Hayami M
Archives of virology 2004 Sep;149(9):1705-20
Archives of virology 2004 Sep;149(9):1705-20
Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination.
Enose Y, Kita M, Yamamoto T, Suzuki H, Miyake A, Horiuchi R, Ibuki K, Kaneyasu K, Kuwata T, Takahashi E, Sakai K, Shinohara K, Miura T, Hayami M
Archives of virology 2004 Sep;149(9):1705-20
Archives of virology 2004 Sep;149(9):1705-20
Simian immunodeficiency virus infection of CD4+CD8+ T cells in a macaque with an unusually high peripheral CD4+CD8+ T lymphocyte count.
Khatissian E, Monceaux V, Cumont MC, Ho Tsong Fang R, Estaquier J, Hurtrel B
AIDS research and human retroviruses 2003 Apr;19(4):267-74
AIDS research and human retroviruses 2003 Apr;19(4):267-74
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
Amara RR, Villinger F, Altman JD, Lydy SL, O'Neil SP, Staprans SI, Montefiori DC, Xu Y, Herndon JG, Wyatt LS, Candido MA, Kozyr NL, Earl PL, Smith JM, Ma HL, Grimm BD, Hulsey ML, McClure HM, McNicholl JM, Moss B, Robinson HL
Vaccine 2002 May 6;20(15):1949-55
Vaccine 2002 May 6;20(15):1949-55
Infection of macaques with a molecular clone, SHIVSF33A2, provides evidence for tissue specific variants.
Buckner CM, Gettie A, Tan RC, Eshetu T, Ratterree M, Blanchard J, Cheng-Mayer C, Harouse JM
Journal of medical primatology 2002 Aug;31(4-5):164-70
Journal of medical primatology 2002 Aug;31(4-5):164-70
CD3 polymorphism in cynomolgus monkeys (Macaca fascicularis).
Uda A, Tanabayashi K, Mukai R, Yachi M, Nam KH, Yamada A
Journal of medical primatology 2001 Jun;30(3):141-7
Journal of medical primatology 2001 Jun;30(3):141-7
The novel immunosuppressant FTY720 induces peripheral lymphodepletion of both T- and B-cells in cynomolgus monkeys when given alone, with Cyclosporine Neoral or with RAD.
Quesniaux VF, Menninger K, Kunkler A, Vedrine C, Bernhard M, Hedinger R, Kraus G, Schuurman HJ
Transplant immunology 2000 Nov;8(3):177-87
Transplant immunology 2000 Nov;8(3):177-87
One-round determination of seven leukocyte subsets in rhesus macaque blood by flow cytometry.
Lafont BA, Gloeckler L, D'Hautcourt JL, Gut JP, Aubertin AM
Cytometry 2000 Nov 1;41(3):193-202
Cytometry 2000 Nov 1;41(3):193-202
One-round determination of seven leukocyte subsets in rhesus macaque blood by flow cytometry.
Lafont BA, Gloeckler L, D'Hautcourt JL, Gut JP, Aubertin AM
Cytometry 2000 Nov 1;41(3):193-202
Cytometry 2000 Nov 1;41(3):193-202
Importance of the CD3 marker for evaluating changes in rhesus macaque CD4/CD8 T-cell ratios.
Dykhuizen M, Ceman J, Mitchen J, Zayas M, MacDougall A, Helgeland J, Rakasz E, Pauza CD
Cytometry 2000 May 1;40(1):69-75
Cytometry 2000 May 1;40(1):69-75
Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus.
Giavedoni LD, Velasquillo MC, Parodi LM, Hubbard GB, Hodara VL
Journal of virology 2000 Feb;74(4):1648-57
Journal of virology 2000 Feb;74(4):1648-57
Cytokine expression, natural killer cell activation, and phenotypic changes in lymphoid cells from rhesus macaques during acute infection with pathogenic simian immunodeficiency virus.
Giavedoni LD, Velasquillo MC, Parodi LM, Hubbard GB, Hodara VL
Journal of virology 2000 Feb;74(4):1648-57
Journal of virology 2000 Feb;74(4):1648-57
Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection.
Chakrabarti LA, Lewin SR, Zhang L, Gettie A, Luckay A, Martin LN, Skulsky E, Ho DD, Cheng-Mayer C, Marx PA
Journal of virology 2000 Feb;74(3):1209-23
Journal of virology 2000 Feb;74(3):1209-23
Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection.
Chakrabarti LA, Lewin SR, Zhang L, Gettie A, Luckay A, Martin LN, Skulsky E, Ho DD, Cheng-Mayer C, Marx PA
Journal of virology 2000 Feb;74(3):1209-23
Journal of virology 2000 Feb;74(3):1209-23
Control mechanisms of virus replication in naturally SIVsmm infected mangabeys and experimentally infected macaques.
Villinger F, Brice GT, Mayne A, Bostik P, Ansari AA
Immunology letters 1999 Mar;66(1-3):37-46
Immunology letters 1999 Mar;66(1-3):37-46
No comments: Submit comment
No validations: Submit validation data